MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea

MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. (“BMS”) to expand genomics solutions in South Korea by leveraging MGI’s cutting-edge technology.

Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of online meetings,

February 12, 2024

Takeda says TYK2 drug it purchased for $4B has passed another mid-stage test

Takeda announced Monday morning that the TYK2 inhibitor it bought from Nimbus Therapeutics for $4 billion has succeeded in a Phase IIb trial in psoriatic

September 12, 2023

7wireVentures Launches $217M Growth & Opportunity Fund

What You Should Know: – 7wireVentures, one of the country’s leading digital health venture capital firms, today announced the successful completion of a $217 million

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.